Janssen Search
Search results
Johnson & Johnson to Acquire Ambrx, Advancing Next Generation Antibody Drug Conjugates to Transform the Treatment of Cancer
Jan 08, 2024 United States Portfolio of Clinical and Preclinical Programs, Including Lead Product Candidate ARX517, a Prostate-Specific Membrane Antigen (PSMA)-Targeting Antibody Drug Conjugate (ADC), Strengthens Johnson & Johnson's Commitment to ...
BIO-Europe Spring 2019
The 13th annual BIO-Europe Spring 2019 will take place March 25–27, 2019, in Vienna, Austria. The conference brings together hundreds of the world’s most innovative leaders across biotech, finance and pharma for high-level networking, pre-scheduled ...
BIO-Europe Spring 2021
The 15th annual BIO-Europe Spring 2021 will take place virtually March 22–25. The conference brings together hundreds of the world’s most innovative leaders across biotech, finance and pharma for high-level networking, pre-scheduled partnering meetings, ...
Kevin Wildenhaus, Ph.D.
As the Behavioral Science Lead for the Disease Interception Accelerator (DIA), Kevin Wildenhaus leads the behavioral science innovation and research efforts for the DIA and its venture focus areas. He is also heading work in perinatal depression to ...
Murray McKinnon, Ph.D.
MURRAY MCKINNON, PH.D. GLOBAL HEAD WORLD WITHOUT DISEASE ACCELERATOR As Global Head of the World Without Disease Accelerator (WWDA), Murray leads a team focused on catalyzing a paradigm shift from disease care to health care through novel approaches to ...
Joyce Lee
JOYCE LEE CHIEF INFORMATION OFFICER (CIO) PHARMACEUTICALS Joyce Lee is the Chief Information Officer (CIO), Pharmaceuticals. Joyce also serves on the Pharmaceuticals Group Operating Committee (GOC). Previously, Joyce served as Vice President and CIO of VF ...
Deidre Meehan
DEIDRE MEEHAN WORLDWIDE VICE PRESIDENT GENERAL COUNSEL PHARMACEUTICALS Deidre Meehan is Worldwide Vice President, General Counsel, Pharmaceuticals. Deidre serves on the Law Department Legal Leadership Team and manages the Pharmaceuticals Legal Group ...
John Gerecitano, M.D., Ph.D.
JOHN GERECITANO, M.D., PH.D. GLOBAL MEDICAL HEAD LYMPHOMA/LEUKEMIA DISEASE AREA LEADER ONCOLOGY RESEARCH & DEVELOPMENT JOHNSON & JOHNSON INNOVATIVE MEDICINE John Gerecitano, M.D., Ph.D. is the Global Medical Head of the Lymphoma/Leukemia Disease ...
Washington University Research Alliance
Research Alliance Marks Innovative Collaboration in Type 1 Diabetes Article Type: World Without Disease Accelerator Disease Interception Accelerator Cardiovascular & Metabolism Partnerships The Disease Interception Accelerator and Janssen ...
The Maturation of Digital Technologies
The Maturation of Digital Technologies Oct 13, 2016 In a Q&A with Clinical Leader magazine, Dmitri Talantov, M.D., R&D Operations Innovation Medical Leader, Janssen Research & Development, LLC, discussed the maturation of digital technologies ...